VNET vs. CDLX, HCAT, SVMK, MGNI, GRND, IAS, GDS, BMBL, HUYA, and MODN
Should you be buying VNET Group stock or one of its competitors? The main competitors of VNET Group include Cardlytics (CDLX), Health Catalyst (HCAT), SVMK (SVMK), Magnite (MGNI), Grindr (GRND), Integral Ad Science (IAS), GDS (GDS), Bumble (BMBL), HUYA (HUYA), and Model N (MODN).
Cardlytics (NASDAQ:CDLX) and VNET Group (NASDAQ:VNET) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.
Cardlytics has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, VNET Group has a beta of -0.31, suggesting that its share price is 131% less volatile than the S&P 500.
In the previous week, VNET Group had 12 more articles in the media than Cardlytics. MarketBeat recorded 14 mentions for VNET Group and 2 mentions for Cardlytics. VNET Group's average media sentiment score of 0.92 beat Cardlytics' score of 0.30 indicating that Cardlytics is being referred to more favorably in the media.
68.1% of Cardlytics shares are held by institutional investors. Comparatively, 72.8% of VNET Group shares are held by institutional investors. 4.4% of Cardlytics shares are held by company insiders. Comparatively, 12.1% of VNET Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Cardlytics has higher earnings, but lower revenue than VNET Group. Cardlytics is trading at a lower price-to-earnings ratio than VNET Group, indicating that it is currently the more affordable of the two stocks.
VNET Group has a net margin of -39.32% compared to VNET Group's net margin of -55.23%. Cardlytics' return on equity of -15.69% beat VNET Group's return on equity.
Cardlytics presently has a consensus target price of $12.75, indicating a potential upside of 45.55%. VNET Group has a consensus target price of $2.85, indicating a potential upside of 46.91%. Given Cardlytics' higher possible upside, analysts clearly believe VNET Group is more favorable than Cardlytics.
VNET Group received 80 more outperform votes than Cardlytics when rated by MarketBeat users. However, 58.20% of users gave Cardlytics an outperform vote while only 57.69% of users gave VNET Group an outperform vote.
Summary
VNET Group beats Cardlytics on 11 of the 18 factors compared between the two stocks.
Get VNET Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for VNET and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VNET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VNET Group Competitors List
Related Companies and Tools
